IL18 and small cell lung carcinoma: Additionally, the sputum supernatants of patients with NSCLC demonstrated a substantially greater proportion of VEGF/IL-18 than those of patients with SCLC, which is likely indicative of a more robust angiogenic effect in NSCLC.76